EU Medicine Authorizations 2025: A Milestone fo...

By HEOR Staff Writer

January 20, 2026

EU Medicine Authorizations 2025: A Year of Innovation Advancements in EU Medicine Authorizations for 2025 In 2025, the European Medicines Agency (EMA) r...
Epidyolex Spending in Portugal Exceeds €3 Million Amid Regulatory Delays
Driving Economic Transformation through Brain Health Investment in Africa
Novartis Drug Pricing Agreement
mRNA Vaccine Advancements: Transforming Infectious Disease Prevention and Equity
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Weight Loss: Advances in Hormone-Based Obesity Treatments
Advancing Kidney Transplant Transparency Through Patient Involvement
AI in South African Healthcare: Professionals’ Confidence in Reducing A...
Health Misinformation Autism: The Dangers of Politicized Science in Vaccine a...
The Market Dynamics of Track One Patent Strategy in Pharmaceuticals
Ending Unproven Fertility Treatments: NICE Calls for Evidence-Based Care in C...
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025